News 20.03.2024 Spineart raises CHF 20 million to push the boundaries of spinal surgery Spineart, the Geneva-based pioneer in spinal surgery innovations, has successfully secured over CHF 20 million in convertible financing.
Aktuell 31.10.2023 Erfahrener Regulatory Compliance Partner Metecon eröffnet Schweizer Niederlassung in Bern Metecon hat Niederlassung in Bern eröffnet: Schweizer Hersteller von Medizinprodukten und IVD werden vor Ort bei der Regulatory Compliance und be...
News 25.10.2023 Mecaplast Swiss, 50 years of innovation in the canton of Fribourg With a rich history spanning five decades, Mecaplast Swiss has consistently proven itself as a leader in the plastic injection industry, particul...
Actualités 26.10.2022 Cordis va acquérir la medtech vaudoise MedAlliance pour USD 1,1 milliard Dans le cadre d’une transaction totale pouvant atteindre USD 1,135 milliard, MedAlliance a signé un accord de sortie avec Cordis, un leader mondi...
News 26.10.2022 Cordis to acquire Vaud-based medtech MedAlliance for up to USD 1.1 billion In a total transaction of up to USD 1.135 billion, MedAlliance has signed an exit agreement with Cordis, a worldwide leader in interventional car...
Industry Report 24.03.2021 Industry Report: Medtech in Korea The import rate in the medical device sector in Korea is higher than 60%. This presents vast business opportunities for Swiss exporters.
Branchenreport 24.03.2021 Branchenreport: Medtech in Korea Die Importquote für medizinische Geräte liegt in Korea bei über 60%. Daraus ergeben sich weitreichende Geschäftschancen für Schweizer Exporteure....
Actualités 27.10.2021 ONWARD Medical entre en bourse et lève CHF 93 millions La spin-off de l'EPFL, ONWARD Medical, est entrée en bourse sur Euronext Bruxelles avec une cotation secondaire sur Euronext Amsterdam, portant l...
News 24.05.2023 Latest research shows 20% of European biotechs now headquartered in Switzerland Press release New research conducted by IQVIA and recently published in the 2023 Swiss Biotech Report shows that 20% of European biotech companies are now head...
News 27.10.2021 ONWARD Medical goes public and raises CHF 93 million EPFL spin-off ONWARD Medical went public on Euronext Brussels with a secondary listing on Euronext Amsterdam, bringing the value of the company t...
Report 27.08.2021 スイスの循環型経済 現在の直線型経済モデルは「take-make-waste」の原則に支配されています。その結果、生態系や天然資源への圧力が増しています。直線型経済モデルは、資源不足や資源の浪費を生み、最後には気候変動や生物多様性損失などの環境危機が生じます。人類は地球の限界(プラネタリー・バウンダリー)を超...
Actualités 24.03.2021 La société medtech MedAlliance lève plus de USD 50 millions pour commercialiser ses ballons à élution de médicament La société nyonnaise MedAlliance a levé plus de USD 50 millions en fonds propres pour son nouveau ballon qui permet une libération contrôlée et p...
News 25.09.2018 GLOBAL TRADE BRIEFING: Database for trade barriers Which of your target export markets have introduced new regulations that could create commercial opportunities or make it harder to supply foreig...
News 24.03.2021 Medtech company MedAlliance raises over USD 50 million to commercialize drug-eluting balloons Vaud-based MedAlliance has raised over USD 50 Million in equity funding for its novel balloon that provides a controlled sustained release of a l...
News 27.11.2018 Export to Japan: “Digitalization offers opportunities for Switzerland” The new head of Swiss Business Hub Japan, Claudio Mazzucchelli, wants to take advantage of new opportunities related to the increasing speed of d...
News 12.12.2022 INTEGRA Biosciences to base half of its production activities in Switzerland Zizers - INTEGRA Biosciences is building a new production facility at its headquarters in the Greater Zurich Area. In future, more than half of t...
Report 21.07.2021 Key Swiss Circular Economy Features In our current linear economic model the principle of "take-make-waste" dominates. This economic model leads to resource scarcity, waste and ulti...